How much should psychedelics researchers disclose about their personal use of psilocybin, ketamine, and other drugs?

Importantly, the Guidebook acknowledges that most psychedelic use happens outside of clinical or regulated contexts. It calls for policy solutions that reflect lived realities, embracing harm ...

Anonymous survey with optional confidential interviews will document how practitioners facilitate MDMA-assisted couples therapyFindings to inform ...

The psychedelic 5-MeO-DMT seemed to induce similar patterns of brain activity in a lama - a revered spiritual teacher in ...

Psychedelic therapy isn’t just about the drug; it’s about the dose, too. Here's why the overlooked middle ground may matter ...

Rick Doblin had come to believe that psychedelic experiences are the "common core" of all religions, and he wanted to test this thesis. In February 1984, the 31-year-old college student living off a ...

Believers in the healing potential of the mind-altering drugs thought RFK Jr. was the answer to their prayers. They’re still waiting.

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with ...

The future of psychedelic research was dealt its biggest setback in years after the FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD) earlier this month, ...

Healing Hearts, Changing Minds (HHCM) today announced the seven awardees of Walking Each Other Home: A Fund to Promote ...

For Tim Ferriss, the best-selling author, podcaster, and investor, the decision to devote his philanthropy to research into psychedelic drugs is built on a solid foundation of peer-reviewed science.